Described herein are compounds, compositions and methods directed to the treatment of ophthalmic conditions characterized by oxidative stress or damage in a subject by reducing the reactive oxygen species in the subject. Also described herein are methods for reducing ophthalmic photooxidative damage in a subject.
申请公布号
WO2009070693(A2)
申请公布日期
2009.06.04
申请号
WO2008US84894
申请日期
2008.11.26
申请人
SIRION THERAPEUTICS, INC;MATA, NATHAN, L.;REID, SILVIA, N.;PHAN, KIM, B.;HAN, YUN;BUI, TAM, V.;HADDACH, MUSTAPHA
发明人
MATA, NATHAN, L.;REID, SILVIA, N.;PHAN, KIM, B.;HAN, YUN;BUI, TAM, V.;HADDACH, MUSTAPHA